Adipose tissue distribution in relation to insulin sensitivity and inflammation in Pakistani and Norwegian subjects with type 2 diabetes

References

• McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337:382–6.
   PubMed Web of Science ®Google Scholar
• Mather HM, Keen H. The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. BMJ (Clin Res Ed) 1985;291:1081–4.
   PubMed Web of Science ®Google Scholar
• Jenum AK, Diep LM, Holmboe-Ottesen G, Holme IM, Kumar BN, Birkeland KI. Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians – the association with adiposity is strongest for ethnic minority women. BMC Public Health 2012;12:150.
   PubMed Web of Science ®Google Scholar
• Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–63.
   PubMed Web of Science ®Google Scholar
• Snehalatha C, Viswanathan V, Ramachandran A. Cut-off values for normal anthropometric variables in asian Indian adults. Diabetes Care 2003;26:1380–4.
   PubMed Web of Science ®Google Scholar
• Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care 2002; 5:481–7.
   PubMed Web of Science ®Google Scholar
• Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, Fujimoto WY. Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 1986;21:483–7.
   PubMed Web of Science ®Google Scholar
• Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941–948.
   PubMed Web of Science ®Google Scholar
• Cancello R, Zulian A, Gentilini D, Maestrini S, Della BA, Invitti C, Cora D, Caselle M, Liuzzi A, Di Blasio AM. Molecular and morphologic characterization of superficial- and deep-subcutaneous adipose tissue subdivisions in human obesity. Obesity (Silver Spring) 2013;21:2562–70.
   PubMed Web of Science ®Google Scholar
• Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999;84:1513–7.
   PubMed Web of Science ®Google Scholar
• Sam S, Haffner S, Davidson MH, D’Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 2009;32:932–7.
   PubMed Web of Science ®Google Scholar
• Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 2011;44: 281–7.
   PubMed Web of Science ®Google Scholar
• Saito T, Murata M, Otani T, Tamemoto H, Kawakami M, Ishikawa SE. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Endocr J 2012;59:39–45.
   PubMed Web of Science ®Google Scholar
• Wium C, Aasheim ET, Ueland T, Michelsen AE, Thorsby PM, Larsen IF, Torjesen PA, Aukrust P, Birkeland KI. Differences in insulin sensitivity, lipid metabolism and inflammation between young adult Pakistani and Norwegian patients with type 2 diabetes: a cross sectional study. BMC Endocr Disord 2013;13:49.
   PubMed Web of Science ®Google Scholar
• Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB, Heshka S. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr 2004;80:271–8.
   PubMed Web of Science ®Google Scholar
• Johnson D, Cormack GC, Abrahams PH, Dixon AK. Computed tomographic observations on subcutaneous fat: implications for liposuction. Plast Reconstr Surg 1996;97: 387–96.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Gastrointest Liver Physiol 1979; 237:G214–223.
   PubMed Web of Science ®Google Scholar
• Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987;317:1098.
   PubMed Web of Science ®Google Scholar
• Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, Iannelli A, Amor IB, Staccini-Myx A, Huet PM, Gugenheim J, Sadoul JL, Le Marchand-Brustel Y, Tran A, Gual P. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol 2006;101:1824–33.
   PubMed Web of Science ®Google Scholar
• Lear SA, Chockalingam A, Kohli S, Richardson CG, Humphries KH. Elevation in cardiovascular disease risk in South Asians is mediated by differences in visceral adipose tissue. Obesity (Silver Spring) 2012;20:1293–300.
   PubMed Web of Science ®Google Scholar
• Lear SA, Humphries KH, Kohli S, Birmingham CL. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity (Silver Spring) 2007; 15:2817–24.
   PubMed Web of Science ®Google Scholar
• Chandalia M, Lin P, Seenivasan T, Livingston EH, Snell PG, Grundy SM, Abate N. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. Public Library of Science One 2007;2:e812.
   Google Scholar
• Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001;25:1327–31.
   PubMed Web of Science ®Google Scholar
• Tran AT, Diep LM, Cooper JG, Claudi T, Straand J, Birkeland K, Ingskog W, Jenum AK. Quality of care for patients with type 2 diabetes in general practice according to patients’ ethnic background: a cross-sectional study from Oslo, Norway. BMC Health Serv Res 2010;10:145.
   PubMed Web of Science ®Google Scholar
• Gabay C, Dreyer M, Pellegrinelli N, Chicheportiche R, Meier CA. Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 2001;86:783–91.
   PubMed Web of Science ®Google Scholar
• Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 2002;87:1184–8.
   PubMed Web of Science ®Google Scholar
• Cartier A, Bergeron J, Poirier P, Almeras N, Tremblay A, Lemieux I, Despres JP. Increased plasma interleukin-1 receptor antagonist levels in men with visceral obesity. Ann Med 2009;41:471–8.
   PubMed Web of Science ®Google Scholar
• Carstensen M, Herder C, Kivimaki M, Jokela M, Roden M, Shipley MJ, Witte DR, Brunner EJ, Tabak AG. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes 2010;59:1222–7.
   PubMed Web of Science ®Google Scholar
• Jenum AK, Holme I, Graff-Iversen S, Birkeland KI. Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention. Diabetologia 2005;48:435–9.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay B, Forouhi NG, Fisher BM, Kesson CM, Sattar N. A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic. Diabet Med 2006;23:94–8.
   PubMed Web of Science ®Google Scholar
• Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43–6.
   PubMedGoogle Scholar